Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206796388> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W3206796388 abstract "Abstract Background Rituximab is known to be associated with a high resolved hepatitis B virus (HBV) reactivation rate in patients with resolved HBV infection and hematologic malignancy. However, data regarding HBV reactivation in rheumatic patients receiving rituximab is limited. Aims To assess the HBV reactivation in HBsAg-negative patients receiving rituximab for autoimmune diseases in a large real-world cohort. Methods From March 2006 to December 2019, 900 patients with negative HBsAg receiving at least one cycle of rituximab for autoimmune diseases in a tertiary medical center in Taiwan were retrospectively reviewed. Clinical outcomes and factors associated with HBV reactivation were analyzed. Results After a median follow-up period of 3.3 years, 21 patients developed HBV reactivation, among which 17 patients were positive for anti-HBc and 4 were negative. Thirteen patients had clinical hepatitis flare, while 8 patients had HBsAg seroreversion without hepatitis. Old age, anti-HBc positivity, and undetectable serum anti-HBs level at rituximab initiation were associated with HBV reactivation. There was no significant difference in the HBV reactivation risk between rheumatoid arthritis and other autoimmune diseases. Among anti-HBc-negative patients, subjects without HBV vaccination at birth had an increased risk of HBV reactivation (4/368, 1.1%) compared with those who received vaccination (0/126, 0%). Conclusions In HBV endemic areas, patients with negative anti-HBc, especially those without vaccination at birth, were still at risk for HBV reactivation after receiving rituximab. Regular monitoring of HBV serology should be considered for all HBsAg-negative patients receiving rituximab for autoimmune diseases." @default.
- W3206796388 created "2021-10-25" @default.
- W3206796388 creator A5001131592 @default.
- W3206796388 creator A5006100250 @default.
- W3206796388 creator A5011005885 @default.
- W3206796388 creator A5015674441 @default.
- W3206796388 creator A5023229596 @default.
- W3206796388 creator A5037214480 @default.
- W3206796388 creator A5062692833 @default.
- W3206796388 creator A5072330393 @default.
- W3206796388 creator A5083863588 @default.
- W3206796388 creator A5090985225 @default.
- W3206796388 creator A5091398336 @default.
- W3206796388 date "2021-09-27" @default.
- W3206796388 modified "2023-10-18" @default.
- W3206796388 title "Risk of Hepatitis B Virus Reactivation in HBsAg-negative, Anti-HBc-negative Patients Receiving Rituximab for Autoimmune Diseases in Hepatitis B Virus Endemic Areas" @default.
- W3206796388 doi "https://doi.org/10.21203/rs.3.rs-927997/v1" @default.
- W3206796388 hasPublicationYear "2021" @default.
- W3206796388 type Work @default.
- W3206796388 sameAs 3206796388 @default.
- W3206796388 citedByCount "0" @default.
- W3206796388 crossrefType "posted-content" @default.
- W3206796388 hasAuthorship W3206796388A5001131592 @default.
- W3206796388 hasAuthorship W3206796388A5006100250 @default.
- W3206796388 hasAuthorship W3206796388A5011005885 @default.
- W3206796388 hasAuthorship W3206796388A5015674441 @default.
- W3206796388 hasAuthorship W3206796388A5023229596 @default.
- W3206796388 hasAuthorship W3206796388A5037214480 @default.
- W3206796388 hasAuthorship W3206796388A5062692833 @default.
- W3206796388 hasAuthorship W3206796388A5072330393 @default.
- W3206796388 hasAuthorship W3206796388A5083863588 @default.
- W3206796388 hasAuthorship W3206796388A5090985225 @default.
- W3206796388 hasAuthorship W3206796388A5091398336 @default.
- W3206796388 hasBestOaLocation W32067963881 @default.
- W3206796388 hasConcept C126322002 @default.
- W3206796388 hasConcept C159654299 @default.
- W3206796388 hasConcept C203014093 @default.
- W3206796388 hasConcept C22070199 @default.
- W3206796388 hasConcept C2522874641 @default.
- W3206796388 hasConcept C2776029263 @default.
- W3206796388 hasConcept C2777203481 @default.
- W3206796388 hasConcept C2777382497 @default.
- W3206796388 hasConcept C2777410769 @default.
- W3206796388 hasConcept C2780593183 @default.
- W3206796388 hasConcept C2780653079 @default.
- W3206796388 hasConcept C71924100 @default.
- W3206796388 hasConceptScore W3206796388C126322002 @default.
- W3206796388 hasConceptScore W3206796388C159654299 @default.
- W3206796388 hasConceptScore W3206796388C203014093 @default.
- W3206796388 hasConceptScore W3206796388C22070199 @default.
- W3206796388 hasConceptScore W3206796388C2522874641 @default.
- W3206796388 hasConceptScore W3206796388C2776029263 @default.
- W3206796388 hasConceptScore W3206796388C2777203481 @default.
- W3206796388 hasConceptScore W3206796388C2777382497 @default.
- W3206796388 hasConceptScore W3206796388C2777410769 @default.
- W3206796388 hasConceptScore W3206796388C2780593183 @default.
- W3206796388 hasConceptScore W3206796388C2780653079 @default.
- W3206796388 hasConceptScore W3206796388C71924100 @default.
- W3206796388 hasLocation W32067963881 @default.
- W3206796388 hasOpenAccess W3206796388 @default.
- W3206796388 hasPrimaryLocation W32067963881 @default.
- W3206796388 hasRelatedWork W1995109981 @default.
- W3206796388 hasRelatedWork W2057974065 @default.
- W3206796388 hasRelatedWork W2101067550 @default.
- W3206796388 hasRelatedWork W2792580651 @default.
- W3206796388 hasRelatedWork W3006180737 @default.
- W3206796388 hasRelatedWork W3084555333 @default.
- W3206796388 hasRelatedWork W3136756476 @default.
- W3206796388 hasRelatedWork W4224012567 @default.
- W3206796388 hasRelatedWork W4318914477 @default.
- W3206796388 hasRelatedWork W4380906651 @default.
- W3206796388 isParatext "false" @default.
- W3206796388 isRetracted "false" @default.
- W3206796388 magId "3206796388" @default.
- W3206796388 workType "article" @default.